Vantawith AdaptiveStim Technology - Model 977006
Medtronic Neuromodulation · Decision date Sep 24, 2026
What did the FDA decide?
The FDA record lists this action for Vanta™ with AdaptiveStim™ Technology, Model 977006, under PMA number P840001, supplement S634, decided OK30 on 2026-09-24. The product code is LGW, device category stimulator, spinal-cord, totally implanted for pain relief, specialty Neurology, applicant Medtronic Neuromodulation. The supplement is a 30-Day Notice with reason Process Change - Manufacturer/Sterilizer/Packager/Supplier.
The reported statement describes approval for a manufacturing process change that will update the manufacturing execution system flow for the affected feedthrough product family. Because P840001 is the original PMA identifier, this supplement sits under that approval rather than constituting a new approval of the whole system. The record does not identify which feedthroughs are affected, the specific MES steps changed, or provide evidence of safety or clinical effectiveness; the statement is a reported purpose, not independent proof.
FDA approval order statement
approval for implementation of a manufacturing process change that will update the manufacturing execution system flow for the affected feedthrough product family
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Neurology
- Decision date
- Sep 24, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P840001/S634
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic Neuromodulation
- Product code
- LGW
- Decision code
- OK30
- Decision date
- Sep 24, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, spinal-cord, totally implanted for pain relief.
- Applicant
- Medtronic Neuromodulation
- Product code
- LGW
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P840001. Subsequent supplements may change the device or its indications.
FDA decision timeline
P840001 · Original PMA
ITREL(R) TOTALLY IMPLANTABLE SPINAL CORD STIM. SYS
P840001/S634 received
Application receipt date recorded by FDA.
P840001/S634 · FDA decision
30-Day Notice
P840001/S632 · Related supplement
Master Vanta with Restore, Itrel, Synergy, Intellis, AdaptiveStim Vanta and Inceptiv TM Spinal Cord Implantable S
P840001/S635 · Related supplement
Master Restore, Itrel, Synergy Intellis, Vanta and Inceptiv Spinal Cord Stimulation Systems and Pisces, Specify,
P840001/S636 · Related supplement
Restore, Itrel, Synergy, Intellis, Vanta and Inceptiv Spinal Cord Stimulation Systems and Pisces-Quad, Specify,
Timeline entries are records held by MedtechLedger for P840001. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P840001
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic Neuromodulation | PMA approval | Nov 30, 1984 | FDA | |
| Medtronic Neuromodulation | PMA supplement | Oct 6, 2026 | FDA | |
| Medtronic Neuromodulation | PMA supplement | Oct 29, 2026 | FDA | |
| Medtronic Neuromodulation | PMA supplement | Oct 30, 2026 | FDA |
Explore the linked device profile
Other records with product code LGW
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA supplement | Oct 30, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Oct 30, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Oct 28, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Oct 27, 2026 | FDA | |
Saluda Medical Evoke SCS SystemP190002/S052 | Saluda Medical Pty, Ltd. | PMA supplement | Oct 16, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic Neuromodulation
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 7000 Central Ave., NE, Minneapolis, MN, 55432
Sources and methodology
- Original FDA record: P840001/S634
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




